Report Overview
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
The global Personalized Medicines market size was estimated at USD 259380 million in 2023 and is projected to reach USD 658143.20 million by 2032, exhibiting a CAGR of 10.90% during the forecast period.
North America Personalized Medicines market size was estimated at USD 80806.09 million in 2023, at a CAGR of 9.34% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Personalized Medicines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Personalized Medicines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Personalized Medicines market in any manner.
Global Personalized Medicines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Market Segmentation (by Type)
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Market Segmentation (by Application)
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
Geographic Segmentation
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Personalized Medicines
1.2 Key Market Segments
1.2.1 Personalized Medicines Segment by Type
1.2.2 Personalized Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Personalized Medicines Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Personalized Medicines Market Competitive Landscape
3.1 Global Personalized Medicines Revenue Market Share by Company (2019-2025)
3.2 Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Personalized Medicines Market Size Sites, Area Served, Product Type
3.4 Personalized Medicines Market Competitive Situation and Trends
3.4.1 Personalized Medicines Market Concentration Rate
3.4.2 Global 5 and 10 Largest Personalized Medicines Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Personalized Medicines Value Chain Analysis
4.1 Personalized Medicines Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Personalized Medicines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Personalized Medicines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Medicines Market Size Market Share by Type (2019-2025)
6.3 Global Personalized Medicines Market Size Growth Rate by Type (2019-2025)
7 Personalized Medicines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Medicines Market Size (M USD) by Application (2019-2025)
7.3 Global Personalized Medicines Market Size Growth Rate by Application (2019-2025)
8 Personalized Medicines Market Segmentation by Region
8.1 Global Personalized Medicines Market Size by Region
8.1.1 Global Personalized Medicines Market Size by Region
8.1.2 Global Personalized Medicines Market Size Market Share by Region
8.2 North America
8.2.1 North America Personalized Medicines Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Personalized Medicines Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Personalized Medicines Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Personalized Medicines Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Personalized Medicines Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 3G Biotech
9.1.1 3G Biotech Personalized Medicines Basic Information
9.1.2 3G Biotech Personalized Medicines Product Overview
9.1.3 3G Biotech Personalized Medicines Product Market Performance
9.1.4 3G Biotech Personalized Medicines SWOT Analysis
9.1.5 3G Biotech Business Overview
9.1.6 3G Biotech Recent Developments
9.2 Quest Diagnostics
9.2.1 Quest Diagnostics Personalized Medicines Basic Information
9.2.2 Quest Diagnostics Personalized Medicines Product Overview
9.2.3 Quest Diagnostics Personalized Medicines Product Market Performance
9.2.4 Quest Diagnostics Personalized Medicines SWOT Analysis
9.2.5 Quest Diagnostics Business Overview
9.2.6 Quest Diagnostics Recent Developments
9.3 Laboratory Corporation of America
9.3.1 Laboratory Corporation of America Personalized Medicines Basic Information
9.3.2 Laboratory Corporation of America Personalized Medicines Product Overview
9.3.3 Laboratory Corporation of America Personalized Medicines Product Market Performance
9.3.4 Laboratory Corporation of America Personalized Medicines SWOT Analysis
9.3.5 Laboratory Corporation of America Business Overview
9.3.6 Laboratory Corporation of America Recent Developments
9.4 Abbott
9.4.1 Abbott Personalized Medicines Basic Information
9.4.2 Abbott Personalized Medicines Product Overview
9.4.3 Abbott Personalized Medicines Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Agendia NV
9.5.1 Agendia NV Personalized Medicines Basic Information
9.5.2 Agendia NV Personalized Medicines Product Overview
9.5.3 Agendia NV Personalized Medicines Product Market Performance
9.5.4 Agendia NV Business Overview
9.5.5 Agendia NV Recent Developments
9.6 Asuragen Inc
9.6.1 Asuragen Inc Personalized Medicines Basic Information
9.6.2 Asuragen Inc Personalized Medicines Product Overview
9.6.3 Asuragen Inc Personalized Medicines Product Market Performance
9.6.4 Asuragen Inc Business Overview
9.6.5 Asuragen Inc Recent Developments
9.7 Becton Dickinson
9.7.1 Becton Dickinson Personalized Medicines Basic Information
9.7.2 Becton Dickinson Personalized Medicines Product Overview
9.7.3 Becton Dickinson Personalized Medicines Product Market Performance
9.7.4 Becton Dickinson Business Overview
9.7.5 Becton Dickinson Recent Developments
9.8 CardioDx Inc.
9.8.1 CardioDx Inc. Personalized Medicines Basic Information
9.8.2 CardioDx Inc. Personalized Medicines Product Overview
9.8.3 CardioDx Inc. Personalized Medicines Product Market Performance
9.8.4 CardioDx Inc. Business Overview
9.8.5 CardioDx Inc. Recent Developments
9.9 Foundation Medicine
9.9.1 Foundation Medicine Personalized Medicines Basic Information
9.9.2 Foundation Medicine Personalized Medicines Product Overview
9.9.3 Foundation Medicine Personalized Medicines Product Market Performance
9.9.4 Foundation Medicine Business Overview
9.9.5 Foundation Medicine Recent Developments
9.10 Qiagen
9.10.1 Qiagen Personalized Medicines Basic Information
9.10.2 Qiagen Personalized Medicines Product Overview
9.10.3 Qiagen Personalized Medicines Product Market Performance
9.10.4 Qiagen Business Overview
9.10.5 Qiagen Recent Developments
9.11 Siemens Healthcare
9.11.1 Siemens Healthcare Personalized Medicines Basic Information
9.11.2 Siemens Healthcare Personalized Medicines Product Overview
9.11.3 Siemens Healthcare Personalized Medicines Product Market Performance
9.11.4 Siemens Healthcare Business Overview
9.11.5 Siemens Healthcare Recent Developments
9.12 Amgen
9.12.1 Amgen Personalized Medicines Basic Information
9.12.2 Amgen Personalized Medicines Product Overview
9.12.3 Amgen Personalized Medicines Product Market Performance
9.12.4 Amgen Business Overview
9.12.5 Amgen Recent Developments
9.13 Bristol-Myers Squibb
9.13.1 Bristol-Myers Squibb Personalized Medicines Basic Information
9.13.2 Bristol-Myers Squibb Personalized Medicines Product Overview
9.13.3 Bristol-Myers Squibb Personalized Medicines Product Market Performance
9.13.4 Bristol-Myers Squibb Business Overview
9.13.5 Bristol-Myers Squibb Recent Developments
9.14 GE Healthcare
9.14.1 GE Healthcare Personalized Medicines Basic Information
9.14.2 GE Healthcare Personalized Medicines Product Overview
9.14.3 GE Healthcare Personalized Medicines Product Market Performance
9.14.4 GE Healthcare Business Overview
9.14.5 GE Healthcare Recent Developments
9.15 Pfizer
9.15.1 Pfizer Personalized Medicines Basic Information
9.15.2 Pfizer Personalized Medicines Product Overview
9.15.3 Pfizer Personalized Medicines Product Market Performance
9.15.4 Pfizer Business Overview
9.15.5 Pfizer Recent Developments
9.16 Sanofi
9.16.1 Sanofi Personalized Medicines Basic Information
9.16.2 Sanofi Personalized Medicines Product Overview
9.16.3 Sanofi Personalized Medicines Product Market Performance
9.16.4 Sanofi Business Overview
9.16.5 Sanofi Recent Developments
9.17 23andMe
9.17.1 23andMe Personalized Medicines Basic Information
9.17.2 23andMe Personalized Medicines Product Overview
9.17.3 23andMe Personalized Medicines Product Market Performance
9.17.4 23andMe Business Overview
9.17.5 23andMe Recent Developments
9.18 Illumina
9.18.1 Illumina Personalized Medicines Basic Information
9.18.2 Illumina Personalized Medicines Product Overview
9.18.3 Illumina Personalized Medicines Product Market Performance
9.18.4 Illumina Business Overview
9.18.5 Illumina Recent Developments
10 Personalized Medicines Regional Market Forecast
10.1 Global Personalized Medicines Market Size Forecast
10.2 Global Personalized Medicines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Personalized Medicines Market Size Forecast by Country
10.2.3 Asia Pacific Personalized Medicines Market Size Forecast by Region
10.2.4 South America Personalized Medicines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Personalized Medicines by Country
11 Forecast Market by Type and by Application (2025-2032)
11.1 Global Personalized Medicines Market Forecast by Type (2025-2032)
11.2 Global Personalized Medicines Market Forecast by Application (2025-2032)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Personalized Medicines Market Size Comparison by Region (M USD)
Table 5. Global Personalized Medicines Revenue (M USD) by Company (2019-2025)
Table 6. Global Personalized Medicines Revenue Share by Company (2019-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2022)
Table 8. Company Personalized Medicines Market Size Sites and Area Served
Table 9. Company Personalized Medicines Product Type
Table 10. Global Personalized Medicines Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Personalized Medicines
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Personalized Medicines Market Challenges
Table 18. Global Personalized Medicines Market Size by Type (M USD)
Table 19. Global Personalized Medicines Market Size (M USD) by Type (2019-2025)
Table 20. Global Personalized Medicines Market Size Share by Type (2019-2025)
Table 21. Global Personalized Medicines Market Size Growth Rate by Type (2019-2025)
Table 22. Global Personalized Medicines Market Size by Application
Table 23. Global Personalized Medicines Market Size by Application (2019-2025) & (M USD)
Table 24. Global Personalized Medicines Market Share by Application (2019-2025)
Table 25. Global Personalized Medicines Market Size Growth Rate by Application (2019-2025)
Table 26. Global Personalized Medicines Market Size by Region (2019-2025) & (M USD)
Table 27. Global Personalized Medicines Market Size Market Share by Region (2019-2025)
Table 28. North America Personalized Medicines Market Size by Country (2019-2025) & (M USD)
Table 29. Europe Personalized Medicines Market Size by Country (2019-2025) & (M USD)
Table 30. Asia Pacific Personalized Medicines Market Size by Region (2019-2025) & (M USD)
Table 31. South America Personalized Medicines Market Size by Country (2019-2025) & (M USD)
Table 32. Middle East and Africa Personalized Medicines Market Size by Region (2019-2025) & (M USD)
Table 33. 3G Biotech Personalized Medicines Basic Information
Table 34. 3G Biotech Personalized Medicines Product Overview
Table 35. 3G Biotech Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 36. 3G Biotech Personalized Medicines SWOT Analysis
Table 37. 3G Biotech Business Overview
Table 38. 3G Biotech Recent Developments
Table 39. Quest Diagnostics Personalized Medicines Basic Information
Table 40. Quest Diagnostics Personalized Medicines Product Overview
Table 41. Quest Diagnostics Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 42. Quest Diagnostics Personalized Medicines SWOT Analysis
Table 43. Quest Diagnostics Business Overview
Table 44. Quest Diagnostics Recent Developments
Table 45. Laboratory Corporation of America Personalized Medicines Basic Information
Table 46. Laboratory Corporation of America Personalized Medicines Product Overview
Table 47. Laboratory Corporation of America Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 48. Laboratory Corporation of America Personalized Medicines SWOT Analysis
Table 49. Laboratory Corporation of America Business Overview
Table 50. Laboratory Corporation of America Recent Developments
Table 51. Abbott Personalized Medicines Basic Information
Table 52. Abbott Personalized Medicines Product Overview
Table 53. Abbott Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 54. Abbott Business Overview
Table 55. Abbott Recent Developments
Table 56. Agendia NV Personalized Medicines Basic Information
Table 57. Agendia NV Personalized Medicines Product Overview
Table 58. Agendia NV Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 59. Agendia NV Business Overview
Table 60. Agendia NV Recent Developments
Table 61. Asuragen Inc Personalized Medicines Basic Information
Table 62. Asuragen Inc Personalized Medicines Product Overview
Table 63. Asuragen Inc Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 64. Asuragen Inc Business Overview
Table 65. Asuragen Inc Recent Developments
Table 66. Becton Dickinson Personalized Medicines Basic Information
Table 67. Becton Dickinson Personalized Medicines Product Overview
Table 68. Becton Dickinson Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 69. Becton Dickinson Business Overview
Table 70. Becton Dickinson Recent Developments
Table 71. CardioDx Inc. Personalized Medicines Basic Information
Table 72. CardioDx Inc. Personalized Medicines Product Overview
Table 73. CardioDx Inc. Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 74. CardioDx Inc. Business Overview
Table 75. CardioDx Inc. Recent Developments
Table 76. Foundation Medicine Personalized Medicines Basic Information
Table 77. Foundation Medicine Personalized Medicines Product Overview
Table 78. Foundation Medicine Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 79. Foundation Medicine Business Overview
Table 80. Foundation Medicine Recent Developments
Table 81. Qiagen Personalized Medicines Basic Information
Table 82. Qiagen Personalized Medicines Product Overview
Table 83. Qiagen Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 84. Qiagen Business Overview
Table 85. Qiagen Recent Developments
Table 86. Siemens Healthcare Personalized Medicines Basic Information
Table 87. Siemens Healthcare Personalized Medicines Product Overview
Table 88. Siemens Healthcare Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 89. Siemens Healthcare Business Overview
Table 90. Siemens Healthcare Recent Developments
Table 91. Amgen Personalized Medicines Basic Information
Table 92. Amgen Personalized Medicines Product Overview
Table 93. Amgen Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 94. Amgen Business Overview
Table 95. Amgen Recent Developments
Table 96. Bristol-Myers Squibb Personalized Medicines Basic Information
Table 97. Bristol-Myers Squibb Personalized Medicines Product Overview
Table 98. Bristol-Myers Squibb Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Recent Developments
Table 101. GE Healthcare Personalized Medicines Basic Information
Table 102. GE Healthcare Personalized Medicines Product Overview
Table 103. GE Healthcare Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 104. GE Healthcare Business Overview
Table 105. GE Healthcare Recent Developments
Table 106. Pfizer Personalized Medicines Basic Information
Table 107. Pfizer Personalized Medicines Product Overview
Table 108. Pfizer Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 109. Pfizer Business Overview
Table 110. Pfizer Recent Developments
Table 111. Sanofi Personalized Medicines Basic Information
Table 112. Sanofi Personalized Medicines Product Overview
Table 113. Sanofi Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 114. Sanofi Business Overview
Table 115. Sanofi Recent Developments
Table 116. 23andMe Personalized Medicines Basic Information
Table 117. 23andMe Personalized Medicines Product Overview
Table 118. 23andMe Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 119. 23andMe Business Overview
Table 120. 23andMe Recent Developments
Table 121. Illumina Personalized Medicines Basic Information
Table 122. Illumina Personalized Medicines Product Overview
Table 123. Illumina Personalized Medicines Revenue (M USD) and Gross Margin (2019-2025)
Table 124. Illumina Business Overview
Table 125. Illumina Recent Developments
Table 126. Global Personalized Medicines Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. North America Personalized Medicines Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Personalized Medicines Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Asia Pacific Personalized Medicines Market Size Forecast by Region (2025-2032) & (M USD)
Table 130. South America Personalized Medicines Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Middle East and Africa Personalized Medicines Market Size Forecast by Country (2025-2032) & (M USD)
Table 132. Global Personalized Medicines Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Personalized Medicines Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Industrial Chain of Personalized Medicines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Medicines Market Size (M USD), 2019-2032
Figure 5. Global Personalized Medicines Market Size (M USD) (2019-2032)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Personalized Medicines Market Size by Country (M USD)
Figure 10. Global Personalized Medicines Revenue Share by Company in 2023
Figure 11. Personalized Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Personalized Medicines Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Personalized Medicines Market Share by Type
Figure 15. Market Size Share of Personalized Medicines by Type (2019-2025)
Figure 16. Market Size Market Share of Personalized Medicines by Type in 2022
Figure 17. Global Personalized Medicines Market Size Growth Rate by Type (2019-2025)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Personalized Medicines Market Share by Application
Figure 20. Global Personalized Medicines Market Share by Application (2019-2025)
Figure 21. Global Personalized Medicines Market Share by Application in 2022
Figure 22. Global Personalized Medicines Market Size Growth Rate by Application (2019-2025)
Figure 23. Global Personalized Medicines Market Size Market Share by Region (2019-2025)
Figure 24. North America Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 25. North America Personalized Medicines Market Size Market Share by Country in 2023
Figure 26. U.S. Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 27. Canada Personalized Medicines Market Size (M USD) and Growth Rate (2019-2025)
Figure 28. Mexico Personalized Medicines Market Size (Units) and Growth Rate (2019-2025)
Figure 29. Europe Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 30. Europe Personalized Medicines Market Size Market Share by Country in 2023
Figure 31. Germany Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 32. France Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 33. U.K. Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 34. Italy Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 35. Russia Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 36. Asia Pacific Personalized Medicines Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Personalized Medicines Market Size Market Share by Region in 2023
Figure 38. China Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 39. Japan Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 40. South Korea Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 41. India Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 42. Southeast Asia Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 43. South America Personalized Medicines Market Size and Growth Rate (M USD)
Figure 44. South America Personalized Medicines Market Size Market Share by Country in 2023
Figure 45. Brazil Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 46. Argentina Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 47. Columbia Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 48. Middle East and Africa Personalized Medicines Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Personalized Medicines Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 51. UAE Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 52. Egypt Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 53. Nigeria Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 54. South Africa Personalized Medicines Market Size and Growth Rate (2019-2025) & (M USD)
Figure 55. Global Personalized Medicines Market Size Forecast by Value (2019-2032) & (M USD)
Figure 56. Global Personalized Medicines Market Share Forecast by Type (2025-2032)
Figure 57. Global Personalized Medicines Market Share Forecast by Application (2025-2032)
